134 related articles for article (PubMed ID: 38087714)
1. An experimental universal swine influenza a virus (IAV) vaccine candidate based on the M2 ectodomain (M2e) peptide does not provide protection against H1N1 IAV challenge in pigs.
Opriessnig T; Gauger PC; Filippsen Favaro P; Rawal G; Magstadt DR; Digard P; Lee HM; Halbur PG
Vaccine; 2024 Jan; 42(2):220-228. PubMed ID: 38087714
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model.
Opriessnig T; Gauger PC; Gerber PF; Castro AMMG; Shen H; Murphy L; Digard P; Halbur PG; Xia M; Jiang X; Tan M
PLoS One; 2018; 13(1):e0191739. PubMed ID: 29381710
[TBL] [Abstract][Full Text] [Related]
3. A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.
Hewitt JS; Karuppannan AK; Tan S; Gauger P; Halbur PG; Gerber PF; De Groot AS; Moise L; Opriessnig T
Vaccine; 2019 Jul; 37(31):4302-4309. PubMed ID: 31248687
[TBL] [Abstract][Full Text] [Related]
4. An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs.
Singh G; Zholobko O; Pillatzki A; Webb B; Nelson E; Voronov A; Ramamoorthy S
Vaccine; 2019 Jul; 37(31):4291-4301. PubMed ID: 31235376
[TBL] [Abstract][Full Text] [Related]
5. Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse.
Mozdzanowska K; Zharikova D; Cudic M; Otvos L; Gerhard W
Virol J; 2007 Oct; 4():118. PubMed ID: 17974006
[TBL] [Abstract][Full Text] [Related]
6. Quadrivalent neuraminidase RNA particle vaccine protects pigs against homologous and heterologous strains of swine influenza virus infection.
Kitikoon P; Knetter SM; Mogler MA; Morgan CL; Hoehn A; Puttamreddy S; Strait EL; Segers RPAM
Vaccine; 2023 Nov; 41(47):6941-6951. PubMed ID: 37884412
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus.
Heinen PP; Rijsewijk FA; de Boer-Luijtze EA; Bianchi ATJ
J Gen Virol; 2002 Aug; 83(Pt 8):1851-1859. PubMed ID: 12124449
[TBL] [Abstract][Full Text] [Related]
8. Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.
Ding P; Jin Q; Chen X; Yang S; Guo J; Xing G; Deng R; Wang A; Zhang G
Int J Nanomedicine; 2019; 14():7533-7548. PubMed ID: 31571862
[TBL] [Abstract][Full Text] [Related]
9. An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.
Zhao G; Sun S; Du L; Xiao W; Ru Z; Kou Z; Guo Y; Yu H; Jiang S; Lone Y; Zheng BJ; Zhou Y
Virol J; 2010 Jul; 7():151. PubMed ID: 20624292
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus.
do Nascimento GM; de Oliveira PSB; Butt SL; Diel DG
Front Immunol; 2024; 15():1322879. PubMed ID: 38482020
[TBL] [Abstract][Full Text] [Related]
11. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
[TBL] [Abstract][Full Text] [Related]
13. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
[TBL] [Abstract][Full Text] [Related]
14. A Universal Influenza Nanovaccine for "Mixing Vessel" Hosts Confers Potential Ability to Block Cross-Species Transmission.
Ding P; Jin Q; Zhou W; Chai Y; Liu X; Wang Y; Chen X; Guo J; Deng R; Gao GF; Zhang G
Adv Healthc Mater; 2019 Aug; 8(16):e1900456. PubMed ID: 31267679
[TBL] [Abstract][Full Text] [Related]
15. A novel M2e based flu vaccine formulation for dogs.
Leclerc D; Rivest M; Babin C; López-Macias C; Savard P
PLoS One; 2013; 8(10):e77084. PubMed ID: 24098576
[TBL] [Abstract][Full Text] [Related]
16. An Orf-Virus (ORFV)-Based Vector Expressing a Consensus H1 Hemagglutinin Provides Protection against Diverse Swine Influenza Viruses.
do Nascimento GM; Bugybayeva D; Patil V; Schrock J; Yadagiri G; Renukaradhya GJ; Diel DG
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112974
[TBL] [Abstract][Full Text] [Related]
17. Polyanhydride nanovaccine against swine influenza virus in pigs.
Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
[TBL] [Abstract][Full Text] [Related]
18. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.
Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH
J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793
[TBL] [Abstract][Full Text] [Related]
19. Vaccination decreases the risk of influenza A virus reassortment but not genetic variation in pigs.
Li C; Culhane MR; Schroeder DC; Cheeran MC; Galina Pantoja L; Jansen ML; Torremorell M
Elife; 2022 Sep; 11():. PubMed ID: 36052992
[TBL] [Abstract][Full Text] [Related]
20. Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies.
Oltean T; Ibanez LI; Divert T; Ysenbaert T; Van Eeckhoutte H; Goossens V; Schotsaert M; Bracke K; Schepens B; Maelfait J; Takahashi N; Saelens X; Vandenabeele P
Cell Death Dis; 2022 Mar; 13(3):280. PubMed ID: 35351865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
